Antibody-Dependent Cellular Cytotoxicity Targeted Against HIV-1 Env Glycans
Pandelakis Koni of the Medical College of Georgia will study the complex sugar coating that surrounds and protects HIV to see if parts of this shield can serve as targets for a vaccine, to generate antibodies that bind to and accelerate the killing of HIV-infected cells.